Produkty 14994-27-5

CAS 14994-27-5 występuje w naszej ofercie pod nazwami: Megestrol Acetate EP Impurity J, Megestrol Acetate Impurity 10（Megestrol Acetate EP Impurity J）, 4,7-Dihydro Megestrol Acetate. Oferty producentów: Chemat Brand, Hubei YoungXin, TRC, Biosynth. Dostępne opakowania: on request, 10mg, 25mg, 50mg, 100mg, 200mg.

Megestrol Acetate EP Impurity J
Chemat Brand
  • opakowanie: on request
  • Warianty: 3
Zobacz produkt
Megestrol Acetate Impurity 10（Megestrol Acetate EP Impurity J）
Hubei YoungXin
  • opakowanie: 10mg, 25mg, 50mg, 100mg
  • Warianty: 5
Zobacz produkt
4,7-Dihydro Megestrol Acetate
TRC, Biosynth
  • opakowanie: 25mg, 50mg, 100mg
  • Warianty: 4
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

[(8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,4,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate (CAS 14994-27-5) to związek chemiczny o wzorze sumarycznym C24H34O4 i masie molowej 386.5 g/mol. Nazwa systematyczna IUPAC: [(8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,4,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate. InChIKey: WYYCRMBIYYRAEW-GQFGMJRRSA-N.

Dane identyfikacyjne
Wzór sumarycznyC24H34O4
Masa molowa386.5 g/mol
Nazwa IUPAC[(8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,4,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
InChIKeyWYYCRMBIYYRAEW-GQFGMJRRSA-N
SMILESCC1=C2CC(=O)CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3C1)CC[C@@]4(C(=O)C)OC(=O)C)C)C

Dane obliczone przez PubChem (NCBI)

Synonimy: 6-Methyl-3,20-dioxopregn-5-en-17-yl acetate, Megestrol Acetate EP Impurity J, 4,7-Dihydro Megestrol Acetate, Pregn-5-ene-3,20-dione, 17-hydroxy-6-methyl-, acetate, Megestrol acetate specified impurity J [EP], MEGESTROL ACETATE IMPURITY J [EP IMPURITY]
Izomery (ten sam wzór sumaryczny)
[(2E,4E,6E,8E)-9-(4-acetyloxy-2,6,6-trimethylcyclohexen-1-yl)-3,7-dimethylnona-2,4,6,8-tetraenyl] acetate C24H34O4
6-[4-[4-(6-hydroxyhexoxy)phenyl]phenoxy]hexan-1-ol C24H34O4
2-methyl-5,6-bis(trideuteriomethoxy)-3-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]cyclohexa-2,5-diene-1,4-dione C24H34O4
[(1S,3R,7S,8S,8aR)-3,7-dimethyl-8-[2-[(2R)-6-oxo-2,3-dihydropyran-2-yl]ethyl]-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate C24H34O4
(1R,2S,4R,8S,9S,12S,13R)-8-acetyl-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icos-17-en-16-one C24H34O4
2,3-dimethoxy-5-methyl-6-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]cyclohexa-2,5-diene-1,4-dione C24H34O4
[(8R,9S,10R,13S,14S,17R)-17-acetyl-3-methoxy-10,13-dimethyl-1,2,7,8,9,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] acetate C24H34O4
(1R,2R,4R,5R,7S,10R,11S,14S,15S,16S,18S,19S)-15-(3-hydroxyprop-1-ynyl)-10,14-dimethylhexacyclo[9.8.0.02,4.05,10.014,19.016,18]nonadecane-5,7,15-triol C24H34O4
[(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate C24H34O4
(1R,2R,4R,5R,10R,11S,14S,15S,16S,18S,19S)-5,5'-dihydroxy-10,14-dimethylspiro[hexacyclo[9.8.0.02,4.05,10.014,19.016,18]nonadecane-15,2'-oxolane]-7-one C24H34O4
(1R,2R,10R,11S,14S,15R)-15-acetyl-17-ethyl-10,14-dimethyl-16,18-dioxapentacyclo[13.3.2.01,14.02,11.05,10]icos-5-en-7-one C24H34O4
[(6R,8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate C24H34O4